Coherus Oncology Inc (NASDAQ: CHRS) on Friday, soared 3.82% from the previous trading day, before settling in for the closing price of $1.31. Within the past 52 weeks, CHRS’s price has moved between $0.71 and $2.43.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -27.36%. The company achieved an average annual earnings per share of -714.73%. With a float of $102.19 million, this company’s outstanding shares have now reached $116.24 million.
Coherus Oncology Inc (CHRS) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Coherus Oncology Inc is 15.46%, while institutional ownership is 41.98%. The most recent insider transaction that took place on May 23 ’25, was worth 73,881. In this transaction Director of this company sold 99,988 shares at a rate of $0.74, taking the stock ownership to the 0 shares.
Coherus Oncology Inc (CHRS) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.28 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.13) by -0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
Coherus Oncology Inc (NASDAQ: CHRS) Trading Performance Indicators
Coherus Oncology Inc (CHRS) is currently performing well based on its current performance indicators. A quick ratio of 1.23 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.59, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.00 in one year’s time.
Technical Analysis of Coherus Oncology Inc (CHRS)
The latest stats from [Coherus Oncology Inc, CHRS] show that its last 5-days average volume of 0.93 million was inferior to 1.55 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 94.53%.
During the past 100 days, Coherus Oncology Inc’s (CHRS) raw stochastic average was set at 50.93%, which indicates a significant decrease from 79.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1105 in the past 14 days, which was higher than the 0.0958 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5344, while its 200-day Moving Average is $1.1058. Now, the first resistance to watch is $1.3880. This is followed by the second major resistance level at $1.4159. The third major resistance level sits at $1.4469. If the price goes on to break the first support level at $1.3291, it is likely to go to the next support level at $1.2981. The third support level lies at $1.2702 if the price breaches the second support level.
Coherus Oncology Inc (NASDAQ: CHRS) Key Stats
Market capitalization of the company is 164.38 million based on 120,871K outstanding shares. Right now, sales total 266,960 K and income totals 28,510 K. The company made 11,570 K in profit during its latest quarter, and -35,530 K in sales during its previous quarter.
